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Abstract
Background: Due to the inherent sensitivity of human embryonic stem cells (hESCs) to manipulations, the recovery and
survival of hESCs after fluorescence-activated cell sorting (FACS) can be low. Additionally, a well characterized and
robust methodology for performing FACS on hESCs using multiple-cell surface markers has not been described. The
p160-Rho-associated coiled kinase (ROCK) inhibitor, Y-27632, previously has been identified as enhancing survival of
hESCs upon single-cell dissociation, as well as enhancing recovery from cryopreservation. Here we examined the
application of Y-27632 to hESCs after FACS to improve survival in both feeder-dependent and feeder-independent
growth conditions.
Methodology/Principal Findings: HESCs were sorted using markers for SSEA-3, TRA-1-81, and SSEA-1. Cells were plated
after sorting for 24 hours in either the presence or the absence of Y-27632. In both feeder-dependent and feeder-
independent conditions, cell survival was greater when Y-27632 was applied to the hESCs after sort. Specifically, treatment
of cells with Y-27632 improved post-sort recovery up to four fold. To determine the long-term effects of sorting with and
without the application of Y-27632, hESCs were further analyzed. Specifically, hESCs sorted with and without the addition of
Y-27632 retained normal morphology, expressed hESC-specific markers as measured by immunocytochemistry and flow
cytometry, and maintained a stable karyotype. In addition, the hESCs could differentiate into three germ layers in vitro and
in vivo in both feeder-dependent and feeder-independent growth conditions.
Conclusions/Significance: The application of Y-27632 to hESCs after cell sorting improves cell recovery with no observed
effect on pluripotency, and enables the consistent recovery of hESCs by FACS using multiple surface markers. This improved
methodology for cell sorting of hESCs will aid many applications such as removal of hESCs from secondary cell types,
identification and isolation of stem cell subpopulations, and generation of single cell clones. Finally, these results
demonstrate an additional application of ROCK inhibition to hESC research.
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Introduction
HESCs have the unique ability to self-renew and give rise to
ectodermal, mesodermal, and endodermal lineages [1,2]. This
capacity to differentiate into cells of all three germ layers provides
an excellent system to study human development and model
disease states. Additionally, as hESCs are a continuously self-
replicating population of cells, they have the potential to be a
stable source of numerous cell types for regenerative medicine.
Unfortunately, hESCs are sensitive to even the most routine
manipulations, such as passaging and cryopreservation, illustrating
the need for technical advancements to realize their full potential
[3,4].
Cell dissociation induced apopotosis has been attributed to the
inherent sensitivity of hESCs and has duly received much
attention. A significant breakthrough for ameliorating this
problem was the identification of Y-27632, a selective inhibitor
of the p160-Rho-associated coiled kinase (ROCK) [5,6], as a
factor that enhanced hESC survival upon single cell dissociation
[7]. Subsequently, Y-27632 has been used in various applications
in stem cell research where extensive cell death occurs. The post-
thaw survival rate was enhanced by the addition of Y-27632 to
hESCs grown in feeder-dependent and independent conditions
and feeder-independent human induced pluripotent stem cells
(hiPSCs) [8–12]. Improved recovery from cryopreservation was
also reported from the addition of Y-27632 to other stem cell types
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marrow-derived mesenchymal stem cells [14]. Inhibition of
ROCK also improved the survival upon dissociation of hESC-
derived cardiomyocyte and non-cardiomyocyte cells [15]. The
recovery upon dissociation as well as the transplantation of neural
precursor cells derived from mouse embryonic stem cells was
positively impacted by the addition of Y-27632 [16]. During
differentiation, Y-27632 was applied to cells to improve survival
upon differentiation of hESCs to retinal cells [17]. In reprogram-
ming, Y-27632 has been used after viral transduction at culture
media exchange to aid in the establishment of hiPSCs [18]. Y-
27632 has also been applied to improve survival of additional cell
types such as endothelial cells [19]and retinal ganglion cells [20].
All together, this body of research has demonstrated the utility and
safety of Y-27632 for a variety of applications and cell types.
The utilization of cell surface markers, including SSEA-3,
SSEA-4, TRA-1-60, TRA-1-81 and SSEA-1 to characterize
hESCs is widely accepted [21,22]. The ability to use these and
other surface markers in combination with FACS to consistently
isolate hESCs and their differentiated progeny would facilitate
many applications. These applications include the removal of
contaminating secondary cell types such as feeders, hESC-derived
fibroblasts and spontaneously differentiating cells, as well as the
identification and isolation of pure subpopulations, genetically
modified cells, and single-cell clones. Thus far, the reported use of
FACS to isolate and consistently recover hESCs has been limited
and variable, necessitating the generation of robust and standard-
ized sorting methods. HESCs have been sorted by the use of light
scatter gating [23] and by the expression of GFP in genetically
altered hESCs lines [24,25]. A combination of sorting using a
fluorescent reporter and SSEA-3 labeling of hESCs with the
successful recovery of cells has also been reported [26].
Interestingly, the only study to date that used more than one
endogenously expressed cell surface marker (SSEA-4 and TRA-1-
81) to sort hESCs resulted in an inability to recover viable cultures
post-sort [27]. All the previously mentioned studies that success-
fully sort hESCs report low recovery. Although a low recovery is to
be expected since sorting of hESCs requires that the cells be
dissociated to a single cell state, it also highlights the necessity for
an improvement in sorting conditions for hESCs.
Since previous studies have shown that the addition of Y-27632
improves the survival of hESCs that have been dissociated to single
cells (for review see [28]), we examined whether Y-27632 would
improve the recovery of hESCs after sorting. Specifically, we
describe that Y-27632 improved the recovery upon sorting of
hESCs using three cell surface markers, SSEA-3 and TRA-1-81
for pluripotency and SSEA-1 to exclude spontaneously differen-
tiating cells in the culture. Cell sorting could be performed on cells
grown in feeder-dependent and feeder-independent growth
conditions. After long-term culturing, sorted cells expressed
markers for pluripotency, differentiated in vitro and in vivo to all
three germ layers, and maintained a stable karyotype.
Materials and Methods
HESC Culture
For feeder-dependent growth conditions, H9 and H7 (WiCell)
hESCs were grown on irradiated mouse embryonic fibroblast
feeder cells in hESC feeder-dependent medium (DMEM-F12,
20% Knockout Serum Replacement, 0.1 mM nonessential amino
acids (all Life Technologies), 2 mM glutamine (Hyclone), 0.1 mM
b-mercaptoethanol (Millipore), and 10 ng/mL recombinant
human bFGF (BD Biosciences)). Cells were passaged using
0.1 mg/ml collagenase IV (Life Technologies). For feeder-
independent growth conditions, hESCs cells (H9 and HUES-9)
were cultured on Falcon plates (BD Biosciences) coated with
Matrigel or Matrigel hESC-qualified Matrix (BD Biosciences) in
mTeSR1 maintenance media (Stem Cell Technologies) according
to manufacturers’ specifications. Feeder-independent hESCs were
passaged with 1 mg/ml dispase (BD Biosciences).
Cell Sorting and Recovery
HESCs were dissociated with Accutase (Innovative Cell
Technologies) and stained using the Human Pluripotent Stem
Cell Sorting and Analysis Kit (BD Biosciences) according to
manufacturers’ directions. Briefly, dissociated cells were passed
through a 70-mm cell strainer (BD Biosciences), treated at room
temperature for 10–15 minutes with 100 units/ml DNase (Sigma),
and stained using FITC anti-SSEA-1, PE anti-SSEA-3, and Alexa
Fluor 647 anti-TRA-1-81 on ice in hESC media containing 5 mM
EDTA (Life Technologies). Cells were subsequently washed in
media containing 5 mM EDTA and resuspended in media
containing 5 mM EDTA at a concentration of 5610
6 cells/mL.
Stained hESCs were sorted on a BD FACSAria II cell sorter at
approximately 20 PSI using a 100-micron nozzle at an average
acquisition rate of 3,000 cells per second into either feeder-
dependent media or mTeSR1. Cells were washed twice in the
appropriate hESC culture media prior to plating at a density of
1.2–2610
6 cells/well of a 6-well dish. Penicillin (100 units/ml)/
streptomycin (100 mg/ml) (Lonza) was added to the hESC cultures
for two weeks after sorting. Y-27632 (Calbiochem) was added to
the hESC media at a concentration of 10 mM at the time of plating
after sorting and removed from the media 24 hours after the sort.
For viability studies, cells were sorted as above or passaged with
Accutase and plated onto a 24-well dish at a density of 4.2610
5
cells/well. Cells were counted 24 hours after plating using a Vi-
CELL analyzer (Beckman Coulter). For pre-treatment studies,
cells were pre-treated with 10 mM Y-27632 for one hour prior to
sort and subsequently sorted as described above. Post-sort, cells
were plated onto a 24-well dish at a density of 2.5610
5 cells/well,
treated with varying concentrations of Y-27632 (0–50 mM ), and
counted 24 hours after plating.
hESC Differentiation
To generate embryoid bodies and to spontaneously differentiate
cells to ectodermal and mesodermal lineages, hESCs were scraped
and placed in hESC feeder-dependent media minus bFGF or in
DMEM-F12 (Life Technologies), 20% FBS (HyClone), 0.1 mM
nonessential amino acids (Life Technologies), 2 mM glutamine
(Hyclone), and 0.1 mM b-mercaptoethanol (Millipore) into low
adhesion plates (Costar) for a period of 7–10 days. Embryoid
bodies were subsequently placed onto 0.1% gelatin (Millipore)
coated dishes for an additional 4–7 days. For directed differen-
tiation to endoderm, hESCs were treated with 100 ng/mL Activin
A (R&D Systems) in low FBS media for three days [29].
Cell Characterization
Cells were grown on Falcon 96-well bioimaging plates (BD
Biosciences), washed with 16 PBS, and fixed with BD Cytofix.
Cells were stained, or permeabilized with 0.1% Triton (Sigma
Aldrich) or BD Phosflow Perm Buffer III and stained.
Cells were stained with the following antibodies for immuno-
fluorescence: Alexa Fluor 555 anti-Tra-1-81 (560123), Alexa Fluor
647 anti-Tra-1-60 (560122), Alexa Fluor 488 anti-SSEA-1
(560172), Alexa Fluor 555 anti-SSEA-4 (560218), Alexa Fluor
647 anti-SSEA-1 (560120), Alexa Fluor 488 anti-Oct-3/4
(560217), Alexa Fluor 647 anti-Sox2 (560294), anti-human Nanog
(560109), Alexa Fluor 488 anti-GATA4 (560332), anti-Desmin
FACS of hESCs Using Y-27632
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(560749), and anti-FoxA2 (all BD Biosciences), anti-Sox17 (R&D
Systems AF1924) and anti-Cardiac Troponin I (cTnI) (Millipore
MAB1691). Purified antibodies were detected using Alexa Fluor
555 and 488 (Life Technologies) secondary antibodies. After
antibody staining, the cell nuclei were counterstained using DAPI
(Sigma Aldrich) or Hoechst (Sigma Aldrich). Cells were imaged on
a Pathway
TM 435 bioimager (BD Biosciences) using a 106
objective and acquired using BD Attovision Software.
FACS analysis was performed using a Human Pluripotent Stem
Cell Sorting and Analysis Kit, a Human and Mouse Pluripotent
Stem Cell Analysis Kit, and a Human Pluripotent Stem Cell
Transcription Factor Analysis Kit (all BD Biosciences). Stained
cells were analyzed on a BD LSR II flow cytometry system using
FACSDiva Software (BD Biosciences).
For in vivo spinal grafting and identification of teratomas, adult
athymic nude (rnu-/rnu-) male rats (320–350 g; n=3 per group)
were anesthetized with isoflurane (1.5–2% maintenance; in room
air), placed into a spinal unit apparatus (Stoelting) and a partial
Th12-L1 laminectomy performed using a dental drill (exposing the
dorsal surface of L2–L5 segments). Using a glass capillary (tip
diameter 80–100 mm) connected to a microinjector (Kopf
Instruments), rats received spinal cell injections (0.5 ml/10,000–
15,000 cell/injection) of hESC lines delivered in DMEF/F12
media. The duration of each injection was 60 s followed by 30 s
pause before capillary withdrawal. The center of the injection was
targeted into the central gray matter (distance from the dorsal
surface of the spinal cord at L3 level approximately: 0.7–0.9 mm)
[30]. Ten injections (500–800 mm rostrocaudally apart) were made
on each side of the lumbar spinal cord. After injections, the
incision was cleaned with penicillin-streptomycin solution and
sutured in two layers. Three or four weeks after cell grafting, rats
were deeply anesthetized with pentobarbital and phenytoin and
transcardially perfused with 200 ml of heparinized saline followed
by 250 ml of 4% paraformaldehyde in PBS. The spinal cords were
dissected and postfixed in 4% formaldehyde in PBS overnight at
4uC. Paraffin-embeded sections (5 mm thick) were then cut and
stained with H&E. Slides were analyzed with Leica (DMLB)
microscope, images captured with Hamamatsu firewire camera
and processed by Adobe Photoshop 7.0 (Adobe Systems).
Karyotyping service was provided by Cell Line Genetics
(Madison, WI).
Results
Sorting strategy for hESCs
HESCs (H9) were grown in feeder-dependent (Fig. 1A) and
feeder-independent (Fig.1B) conditions and routinely passaged in
clusters with either collagenase IV or dispase, respectively. For
sorting, Accutase was chosen to disassociate hESCs given that it
was reported to dissociate hESCs in sorting for GFP positive cells
[31]. For both feeder-dependent and feeder-independent (data not
shown) sorting experiments, single cells of hESCs were first
identified (Fig. 1C), and SSEA-1
2/SSEA-3
+/Tra-1-81
+ cells were
sorted from cultures (Fig. 1D). The percentage of hESCs that were
SSEA-1
2/SSEA-3
+/Tra-1-81
+ pre-sort (83.4%) (Fig. 1D–E) and
Figure 1. Sorting strategy for hESCs. Bright field images of A) H9 hESCs grown on feeders at passage 42 prior to sorting and B) H9 hESCs grown
feeder-free at passage 33 prior to sorting. Cells were stained with SSEA-1, SSEA-3, and TRA-1-81 fluorochrome-conjugated antibodies. C) Single cells
were first identified by light scatter gating, D) SSEA-1
2 cells were gated out and SSEA-3
+TRA-1-81
+ cells were gated and then sorted. E) Gating
hierarchy and F) post-sort purity is shown. Scale bars in (A) and (B) are 100 mm.
doi:10.1371/journal.pone.0012148.g001
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pluripotent hESCs after sorting.
Y-27632 improves recovery upon sorting
Although we were able to routinely recover hESCs by sorting
using cell surface markers, the number of hESCs colonies that
appeared after sorting was low and the colonies took longer to
appear (as compared to passaging) in both feeder-dependent and
feeder-independent conditions. We observed that plating cells at a
higher density post-sort aided in recovery (data not shown). To
further improve post-sort recovery, we applied Y-27632 to hESCs
post-sort. We morphologically compared hESCs grown in feeder-
dependent conditions that were treated with Y-27632 for 24 hours
after sort to hESCs that received no treatment (Fig. 2A). Cells that
received Y-27632 after sorting were visible upon day 1 post-sort
and cells were ready to be passaged day 5 post-sort, whereas the
untreated group was not ready to be passaged until day 9 post-sort.
Similar trends were seen in hESCs grown in feeder-independent
conditions where the addition of Y-27632 improved post-sort
recovery and time to passage (Fig. 2B). Additionally, after Y-27632
treatment, cells had a more flattened morphology and eventually
formed a monolayer in culture (Figure 2); this morphology has
been previously reported upon application of Y-27632 after
passaging and after cryopreservation [9,31]. SSEA-1
2/SSEA-3
+/
Tra-1-81
+ H7 hESCs were also sorted several times but colonies
only appeared in cultures that received Y-27632 post-sort (Fig. S1).
H7 hESCs were not passaged until day 11 post-sort, comparable
to H9 hESCs that were sorted without Y-27632.
To quantitatively assess the impact of Y-27632 on cells during
sorting and during routine passaging, hESCs grown in feeder-
independent conditions were counted at day 1 post-sort and day 1
post-passage. We compared the percent recovery (number of cells
recovered at day 1/number of cells plated) of hESCs that were
plated with and without Y-27632 and either sorted (Fig. 3A) or
Figure 2. Morphology of hESCs after sorting without and with application of Y-27632. Bright field images of H9 hESCs at various days
after sorting without and with Y-27632. A) HESCs grown on feeders (cells were passage 42 prior to sorting) B) HESCs grown feeder-free (cells were
passage 33 prior to sorting). (*) indicates the day at which cells were passaged after the sort. Scale bars are 100 mm.
doi:10.1371/journal.pone.0012148.g002
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were recovered in the presence of Y-27632 as compared to only 2–
19% without Y-27632 (Fig. 3A). Post-passaging, 21–48% of cells
were recovered in the presence of Y-27632 versus 5–34% of cells
without Y-27632 (Fig. 3B). The improved recovery of hESCs by
using Y-27632 after passaging correlates with previous reports [9].
Not surprisingly, due to the increased manipulations involved in
cell sorting, cells that were sorted had a lower percent recovery
than cells that were passaged. The relative fold increase in survival
after sorting and subsequent application of Y-27632 was compared
between different sorts (Fig. 3C). Application of Y-27632 after cell
sorting resulted in a 1.6 to 4 fold increase in survival compared to
sorting without application of Y-27632.
To further define sorting conditions, we assessed whether pre-
treatment of cells with Y-27632 would have an effect on post-sort
recovery. There was no effect when H9 hESCs grown in feeder-
independent conditions were pre-treated with Y-27632 prior to
sorting (Fig. 3D) and this trend was observed in multiple pre-
treatment experiments (data not shown). Additionally, the
concentration of Y-27632 was varied post-sort to see if there was
a dose-dependant impact on survival. In H9 hESCs, while using
less than 10 mM Y-27632 had a negative impact on recovery if no-
pretreatment was performed, there was no dose-dependent effect
on survival at higher concentrations of Y-27632 (Fig. 3D). As
previously reported, pre-treatment of hESC with Y-27632 resulted
in a longer and more laborious cell dissociation [9]. In some cases
we observed up to a 20% decrease in the initial cell population for
sorting if cells were pre-treated with Y-27632 (data not shown). We
also performed pre-treatment and concentration titrations of Y-
27632 on the hESCs cell line HUES-9, to see if trends were
similar. For two of three trials, there was no additive effect on
survival after pre-treatment (Fig. S2B–C). For one trial (Fig. S2A),
there was a positive impact of pre-treatment on survival. We
cannot explain this discrepancy other than inherent variability in
cell preparation during sorting or passaging. For all three trials,
there was no substantial increase in survival at higher doses of Y-
27632. All together, these data suggest that treatment with 10 mM
Y-27632 post-sort is sufficient to improve cell survival. Interest-
Figure 3. Recovery of hESCs grown feeder-free after sorting and passaging without and with Y-27632. Percent recovery of H9 hESCs at
day 1 after A) sorting or B) passaging with Accutase. Percent recovery equals the number of cells recovered at day 1 after passage or sorting divided
by the number of cells plated. A total of two (Trial 3) to three wells (Trials 1, 2 and 4) were counted for each trial group with error bars representing
standard deviation. C) Fold increase in the recovery of cells at day 1 upon addition of Y-27632 after sorting. The number of cells recovered without Y-
27632 was set at 1. D) Percent recovery at day 1 post-sort after pre-treatment of cells with Y-27632 and Y-27632 post-sort titration. A total of three
wells were counted for each trial group with error bars representing standard deviation.
doi:10.1371/journal.pone.0012148.g003
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HUES-9 (30–55%) than with H9 (8–35%). Moreover, we were not
able to reproduce pre-treatment experiments faithfully with the
H7 line due to the sporadic and variable nature of these cells to
recover post-sort. All together, these data highlight differences in
the robustness of hESC lines in recovering from single cell
dissociation and cell sorting.
HESCs sorted with three surface markers and recovered
with Y-27632 maintain pluripotency and a stable
karyotype
HESCs sorted using cell surface markers and treated with Y-
27632 after sorting were cultured for an extended period of time
and subsequently characterized. Sorted cells that were grown in
feeder-dependent conditions (Fig. 4A) and feeder-independent
conditions (Fig. 4E) maintained typical hESCs morphology of
compact colonies with distinct borders. Additionally, cells expressed
various pluripotency markers by immunofluorescence (TRA-1-81,
TRA-1-60, SSEA-3, Oct4, Nanog, and Sox2) and did not express
the differentiation marker SSEA-1 (Fig. 4B–D, F–H). Similar
morphology and marker expression was seen for cells that were
sorted without Y-27632 in feeder-dependent and feeder-indepen-
dent conditions (Fig. S3). To quantitatively assess expression of
pluripotency markers, we analyzed the cells by flow cytometry
(Fig. 4I–J; Fig. S4). Cells sorted in both feeder-dependent (Fig. 4I)
and feeder-independent (Fig. 4J) conditions showed high levels of
pluripotency markers. Cells that were sorted with and without Y-
27632 both expressed high levels of pluripotency markers,
indicating that cells maintained pluripotency after cell sorting. No
differences were observed in the expression of pluripotency markers
in cells that were sorted with and without Y-27632.
Sorted hESC were also examined for their in vitro differentiative
capacity. HESCs sorted with Y-27632 and grown in feeder-
dependent (Fig. 5A) and feeder-independent conditions (Fig. 5E)
were able to form embryoid bodies. Additionally, cells were able to
differentiate into cell types that stained positive for mesoderm
Figure 4. Characterization of hESCs upon extended passaging after sorting with application of Y-27632. A) Bright field image of H9
hESCs cultured on feeders at passage 26 post-sort and day 4 after passaging. B–D) Immunofluorescence labeling of hESCs cultured in feeder-growth
conditions at passage 26 post-sort. E) Bright field image of hESCs cultured in feeder-free growth conditions at passage 10 post-sort and day 3 after
passaging. F–H) Immunofluorescence labeling of hESCs in feeder-free growth conditions at passage 10 post-sort. Post-sort marker expression of H9
hESCs as measured by flow cytometry of I) Passage 14 post-sort on feeders with Y-27632 and passage 13 post-sort without Y-27632 and J) Passage 13
post-sort feeder-free hESCs with and without Y-27632. The percent positive expression from flow cytometry experiments after extended passage
post-sort with and without Y-27632 is shown (data from flow analysis experiments is shown in Fig. S4). Scale bars in (A–H) are 100 mm.
doi:10.1371/journal.pone.0012148.g004
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(Fig. 5C and 5G), and endoderm (FoxA2, Sox17) (Fig. 5D and 5H).
Cells that were sorted without the presence of Y-27632 were also
able to differentiate into all three germ layers (Fig. S5). Sorted
hESCs that were treated with and without Y-27632 had similar
abilities to differentiate to all three germ lineages. Interestingly, we
noticed that cells grown in feeder-independent conditions formed
fewer beating cardiomyocytes. We were unable to obtain any
beating cardiomyocytes in feeder-independent hESCs sorted with
Y-27632 but the cells were able to differentiate to a mesodermal
lineage as evidenced by the expression of desmin (Fig. 5F).
Additionally, hESCs sorted and treated with Y-27632 were able
to differentiate in vivo to all three germ layers. Transverse spinal
cord sections prepared from animals injected with sorted hESCs
grown in feeder-dependent and feeder-independent conditions
showed consistent presence of teratomas. This was accompanied
by spinal gray matter expansion in injected spinal cord segments.
In the majority of sections only a thin rim of residual host tissue in
the ventral horn was still recognizable (Fig. 6A, G; blue asterisks).
Individual germ layers were identified by the presence of ectoderm
(neural rosettes) (Fig. 6E, H; arrows), endoderm (simple columnar
epithelia or goblet cells) (Fig. 6B, J; arrows) and mesoderm ((loose
connective tissue of early muscle (Fig. 6F, I; arrows), the honey-
comb like vacuoles of adipocytes (Fig. 6C, K; asterisks) and newly
formed blood vessels (Fig. 6D)) derivatives.
Sortedcells were passaged for at least16 passages and werefound
to exhibit a normal karyotype in feeder-dependent (Fig. 7A) and
feeder-independent (Fig. 7B) conditions. Additionally, cells sorted
without Y-27632 and cultured long term also exhibited a normal
karyotype (Fig. S6). No differences were observed in the karyotypic
stability of hESCs that were sorted with and without Y-27632.
Discussion
We have demonstrated the ability to consistently recover pure
populations of hESCs by FACS using cell surface markers and Y-
27632. This improved and consistent methodology will aid in the
purification of human pluripotent stem cells from cultures that
have populations of differentiating cells as well as the removal of
various types of feeder layers. Furthermore, as stem cell biology
moves towards cell-based therapies, it is crucial that specific cell
populations be able to be isolated and purified on the basis of their
cell surface signature. Novel markers for sorting of hESC-derived
lineage specific populations [32-35] and more gentle sorting
techniques [36] are being implemented with stem cell populations,
but more studies are required. In addition to hESCs, we predict
that the addition of Y-27632 would assist in post-sort recovery of
various other stem cell types as addition of Y-27632 has enabled
numerous other applications for a variety of cells. Y-27632 has
been beneficial in post-cryopreservation recovery in not only
hESCs [8–11] but also hiPSCs [8,12] as well as non-human
primate embryonic stem cells [13] and mesenchymal stem cells
[14]. However not all cell types benefit from the application of Y-
27632 as fresh and cryopreserved cord blood-derived CD34
+
hematopoietic stem and progenitor cells were adversely affected
upon the application of Y-27632 to cells [37]. Y-27632 has been
used recently for sorting for GFP-positive cells in the recovery of
viral reprogramming factor-free hiPSCs from Parkinson’s patients
[38]. Interestingly, in order to examine crypt organoid formation,
Y-27632 was added post-sort to clone Lgr5-GFP murine crypts
[39]. If Y-27632 is to be added to other stem cell populations and
their derivatives post-sort, it will be important to determine the
effect Y-27632 may have on the long-term phenotype of cells.
Our results indicate that certain hESC lines are more amenable to
FACS than others. This could be due to genotypic differences, cell
culturing methodologies or both. HUES-9 had the most robust
recovery rates after FACS. Interestingly, this line was adapted to
single-cell passaging during its establishment [40]. We hypothesize
that one way to improve the percent recovery in additional hESC
lines would be to first adapt lines to single-cell passaging prior to
FACS. Recent evidence has shown that the addition of Y-27632 to
both media and matrix (Matrigel) results in an increase in survival
after cryopreservation and passaging as opposed to treatment with Y-
27632 in the media alone[41,42]. It would be interesting to examine
if the application of Y-27632 to matrices in addition to media after
sorting would benefit hESC lines, such as H7, that are inherently
more sensitive to sorting. Pretreatment of hESC with Y-27632 has
Figure 5. In vitro differentiative capacity of hESCs upon extended passaging after sorting with Y-27632. Bright field images of A) day 5
embryoid bodies from hESCs on feeders at passage 13 post-sort and E) day 6 embryoid bodies from hESCs feeder-free at passage 12 post-sort.
Immunofluorescence of differentiated hESCs shows labeling for mesoderm (B, F) (GATA4 and cTnI and Desmin), ectoderm (C, G) (Nestin and Sox1),
and endoderm (D, H) (FoxA2, Sox17). For feeder conditions (B–D), hESCs are at passage 14 post-sort (B); passage 13 post-sort (C); and passage 16
post-sort (D). For feeder-free conditions (F–H), hESCs are at passage 12 post-sort (F); passage 12 post-sort (G); and passage 13 post-sort (H). Scale
bars are 100 mm.
doi:10.1371/journal.pone.0012148.g005
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[7,12]. We did not observe the same trend with FACS for the hESC
lines we examined. We suspect that the additional time and manual
titurations required to create a single-cell suspension appropriate for
FACS may have caused significant stress that negated its positive
effect. One proposed mechanism whereby ROCK inhibition leads to
an increase in hESC survival is that the inhibition of Y-27632
increases cell-cell interactions which then allow for aggregates of
hESCs to form [28]. While this mechanism would be useful post-
FACS, it may be counter productive pre-FACS.
Y-27632 was initially identified while screening for modulators
that would increase the low levels of cloning efficiency of hESCs
[7,43]. Previous attempts to clonally derive hESC lines by sorting
using forward and side scatter reported an equally low cloning
efficiency [23]. It would be of interest to sort hESC to clonality
using cells surface makers and our improved methods in cell
preparation and sorting and includeY-27632 post-sort to examine
if this improves the recovery of sorting hESCs to clonality. It
would also be of interest to apply these sorting strategies to sort
pure populations of hiPSCs to obtain clonal hiPSC lines or sort
fully reprogrammed cells from their intermediates in lieu of having
to manually pick colonies [44,45]. Hence, the advances presented
here to successfully sort and recover hESCs using cell surface
markers have applications not only in the purification of hESC but
also could apply to hiPSC populations. Additionally, this is a step
in the direction to advance the use of cell surface markers and flow
cytometry to successfully sort derivates of hESCs that has far
reaching implications in the field of regenerative medicine.
Figure 6. In vivo differentiative capacity of hESCs upon extended passaging after sorting with Y-27632. Hematoxylin and Eosin staining
of cell-injected spinal cords. Teratomas are from hESCs cultured in feeder-dependent growth conditions passage 21 post-sort (A–F) and feeder-
independent growth conditions at passage 12 post-sort (G–K). Individual germ layers were identified by the presence of ectoderm (neural rosettes)
(E, H; arrows), endoderm (simple columnar epithelia or goblet cells) (B, J; arrows) and mesoderm ((loose connective tissue of early muscle (F, I ;
arrows), the honey-comb like vacuoles of adipocytes (C, K; asterisks) and newly formed blood vessels (D) derivatives). Scales bars: (A,G): 300 mm; (H):
50 mm; (J, K): 30 mm; (B, C, D, E, F and I): 20 mm).
doi:10.1371/journal.pone.0012148.g006
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Figure S1 Morphology of hESCs grown on feeders after sorting
with application of Y-27632. Bright field images of H7 hESCs on
feeders (at passage 38 prior to sorting) at various days after sorting
withY-27632.(*)indicatesthedayatwhichcellswerepassagedafter
the sort. H7 hESCs that were not treated with Y-27632 after sorting
did not yield colonies (data not shown). Scale bars are 100 mm.
Found at: doi:10.1371/journal.pone.0012148.s001 (1.47 MB TIF)
Figure S2 Y-27632 pre-treatment of hESCs grown feeder-free
and post-sort Y-27632 titration. Day 1 percent recovery post-sort
of HUES-9 hESCs after pre-treatment of cells with Y-27632 pre-
sort and Y-27632 post-sort titration A–C). Percent recovery equals
the number of cells recovered at day 1 post-sort divided by the
number of cells plated. A total of three wells were counted for each
trial group with error bars representing standard deviation.
Found at: doi:10.1371/journal.pone.0012148.s002 (0.23 MB TIF)
Figure S3 Morphology and immunofluorescence of hESCs
cultured in feeder and feeder-free conditions upon extended
passaging after sorting without the application of Y-27632. A)
Bright field image of H9 hESCs on feeders at passage 25 post-sort
and day 4 after passaging. B–D) Immunofluorescence labeling of
hESCs in feeder growth conditions at passage 25 post-sort. E)
Bright field image of hESCs in feeder-free growth conditions at
passage 10 post-sort and day 3 after passaging. F–H) Immuno-
fluorescence labeling of hESCs in feeder-free growth conditions at
passage 10 post-sort. Scale bars are 100 mm.
Found at: doi:10.1371/journal.pone.0012148.s003 (4.56 MB TIF)
Figure S4 Pluripotency marker expression as measured by flow
cytometry upon extended passaging after sorting without and with
application of Y-27632. Post-sort marker expression of H9 hESCs at A)
Passage 14 post-sort with Y-27632 on feeders, B) Passage 13 post-sort
without Y-27632 on feeders, C) Passage 13 post-sort feeder-free with
Y-27632, and D) Passage 13 post-sort feeder-free without Y-27632.
Found at: doi:10.1371/journal.pone.0012148.s004 (0.34 MB TIF)
Figure S5 In vitro differentiative capacity of hESCs cultured in
feeder and feeder-free conditions upon extended passaging after
sorting without Y-27632. Bright field images of A) day 5 embryoid
bodies from hESCs on feeders at passage 12 post-sort and B) day 6
embryoid bodies from hESCs feeder-free at passage 12 post-sort.
Immunofluorescence of differentiated hESCs shows labeling for
mesoderm (B, F) (GATA4 and cTnI), ectoderm (C, G) (Nestin and
Sox1), and endoderm (D, H) (FoxA2, Sox17). For feeder
conditions (B–D), hESCs are at passage 13 post-sort (B); passage
12 post-sort (C); and passage 15 post-sort (D). For feeder-free
conditions (F–H), hESCs are at passage 20 post-sort (F); passage 12
post-sort (G); and passage 19 post-sort (H). Scale bars are 100 mm.
Found at: doi:10.1371/journal.pone.0012148.s005 (4.87 MB TIF)
Figure S6 Karyotype analysis of hESCs cultured on feeders and
feeder-free conditions upon extended passaging after sort without
application of Y-27632. Post-sort karyotype of H9 hESCs grown
on A) feeders at passage 54 (passage 17 post-sort) without Y-27632
and B) feeder-free at passage 50 (passage 21 feeder-free and
passage 16 post-sort) without Y-27632.
Found at: doi:10.1371/journal.pone.0012148.s006 (0.39 MB TIF)
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